Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR.

Blue Yonder Holding, Inc. (Blue Yonder), the world leader in digital supply chain transformation, today released its Q4 2024 and FY24 company highlights, as well as the industry ...

Government, IoT, and Cybersecurity sectors, announced today that Company has received new orders from a European government customer which locked in over 200% growth in PureTrack GPS units ...

Recent advancements in organic photovoltaics highlight the role of non-fullerene acceptors and secondary hole transport layers in enhancing device efficiency.